我们正在寻找中国人参与临床研究
News
AKL & HAM - 0800 788 3437
CHC & WLG - 0800 862 278

Important Information

If you are interested in applying for this study, please:
  • read the study description.
  • review the Visit Planner dates in your location and confirm that you are available for the stated dates.
  • If you have not yet registered with us, click on the ‘Register’ button at the top of this page and answer the questions.
  • If you have already registered with us, answer the pre-screening questions listed below and submit your interest.

We will then contact you to check your suitability and share the Participant Informed Consent Form for you to read.

Study Information

LTG-001 is being developed for the treatment of acute (short-term) and chronic (long-term) pain. One in five New Zealanders live with persistent pain, making it hard to sleep, work and enjoy life. Current pain therapies are limited and may increase risk of abuse of dependence. There is a large unmet need for new, more effective pain therapies to be available to people who need them.

LTG-001 works by inhibiting (blocking) a certain pathway in the cells which control certain pain sensing neurons. LTG-001 is a non-opioid, non-NSAID (non-steroidal anti-inflammatory) and non-narcotic based pain-relief. It is hoped that, by blocking this pathway in the cells, LTG-001 may be an effective treatment for acute or chronic pain while reducing the likelihood for abuse and dependence.

This is a first-in-human study, for which we have completed 4 cohort trial groups previously. We are looking for healthy volunteers to support the research.

It is an investigational drug because it has not been approved by MedSafe or other drug regulatory authorities.

This study (2023 FULL 18297) is being funded by Latigo and has been approved by the Health and Disability Ethics Committee.

Requirements

  • Aged between 18 – 55 years
  • BMI (Body Mass Index) between 18 – 32 kg/m2
  • Non-smokers/Vapers or Ex-smokers/Vapers within 1 month allowed
  • Not currently taking any regular prescription medications

What is Involved?

Study Visits: 12-night stay + 1 clinic visit

Reimbursement: Up to $6,600 before tax

Important Documents

Important documents to download and read

Pre-screening Form

LEAF MAD

Pre screening for LEAF MAD

Personal details

Please provide your name, email and phone number so we can contact you

Medical questions

Have you had any covid symptoms in the last two weeks or been in isolation?
This study requires the use of contraception during the study. Are you currently using contraception? Women need to be taking/on IUD, OCP etc.
Do you have any history of medical conditions relating to:
Have you donated blood or plasma in the last few months?
Are you currently taking any prescription medication?
What group dates are you available for?
Just to inform you, that you come in for screening at risk. There is no payment for the screening visit, and you may not be offered a position on the study if the group fills up, or you may only be offered a position as a back-up. It is not guaranteed that you will get a full position on the study as it depends on your results as well. Are you comfortable with this?
Pre-screening form policy(Required)
I understand that by submitting this form, NZCR will use the information for pre-screening purposes for this study. This information may be recorded on your profile to allow us to improve our process when screening you for a future study. All information provided is confidential. I also understand that by submitting this form, I will be receiving emails, texts or calls about this study. For more information, please refer to the Privacy Policy.